After surgery for bowel cancer, patients are offered certain chemotherapy types and regimens to reduce the risk of the cancer coming back. However, people may get shorter or longer treatment than recommended, or have their treatment changed or stopped. The study will examine how long chemotherapy is given, how treatment is modified in practice, and whether these patterns vary between patient groups or NHS providers, and whether differences affect survival or toxicity outcomes.